Without trying to sound like a crazy conspiracy theorist, I 100% agree that it's possibly that big pharma played a roll in skewing the US results. It's been done before and I wouldn't blame them for wanting to stop a rival product with zero side effects from entering the market. Results simply make no sense otherwise. Botanix would be fine to just market and sell the US vehicle with the results it gave.
Market seems to have calmed down, buy side is now bigger than the sell side.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-127
-
- There are more pages in this discussion • 524 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |